This compound is a chiral pharmaceutical intermediate featuring a diphenylmethanol group attached to a methylpyrrolidine ring. Its primary significance lies in its use as a building block for the stereoselective synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 144119-12-0
(3S)-piperidin-3-ylmethanol
Pharmaceutical intermediate for chiral synthesis
(alphaR)-alpha-Ethyl-3-fluoro-benzenemethanol
Pharmaceutical intermediate for chiral synthesis
2-[(2R)-2,3-Dihydroxypropyl]-1H-isoindole-1,3(2H)-dione
Pharmaceutical intermediate for chiral synthesis
(1R,2R)-trans-N-Boc-2-aminocyclohexanol
Pharmaceutical intermediate for chiral synthesis
Fmoc-Asp-OAll
Fmoc-protected amino acid building block
Carbamic acid, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester
Pharmaceutical intermediate for peptide synthesis
4-nitrophenyl 1,3-thiazol-5-ylmethyl carbonate
pharmaceutical intermediate
1,3-Thiazol-5-ylmethyl N-[(1S,2S,4S)-4-amino-1-benzyl-2-hydroxy-5-phenylpentyl]carbamate
pharmaceutical intermediate for protease inhibitors
[(2R)-1-methylpyrrolidin-2-yl]-diphenylmethanol
XIJAGFLYYNXCAB-QGZVFWFLSA-N
CN1CCC[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)O